BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kurdi M, Mulla N, Malibary H, Bamaga AK, Fadul MM, Faizo E, Hakamy S, Baeesa S. Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors. World J Clin Oncol 2023; 14(3): 117-130 [PMID: 37009528 DOI: 10.5306/wjco.v14.i3.117]
URL: https://www.wjgnet.com/2218-4333/full/v14/i3/117.htm
Number Citing Articles
1
Tang-Her Jaing, Yi-Lun Wang, Chia-Chi Chiu. Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?Pharmaceuticals 2024; 17(8): 991 doi: 10.3390/ph17080991
2
Serge Yaacoub, Elton Vannoy, Stefanyda Maslova, Abigail Haffey, Khatereh Khorsandi, Natasha Sheybani, Dalia Haydar. CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistenceFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1596499
3
Motaz Fadul, Saleh Baeesa, Alaa Alkhotani, Amany A. Fathaddin, Ahmed I. Lary, Bassam Addass, Taghreed Alsinani, Ahmed Bamaga, Ahmad Albeshri, Mohammed M. Karami, Mohammed A. Abutalib, Maher Kurdi. Exploring IDH1 and IDH2 Mutations in Paediatric MedulloblastomaFolia Biologica 2025; 71(2): 73 doi: 10.14712/fb2025071020073
4
Julian S. Rechberger, Stephanie A. Toll, Wouter J. F. Vanbilloen, David J. Daniels, Soumen Khatua. Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and TreatmentDiagnostics 2023; 13(14): 2398 doi: 10.3390/diagnostics13142398
5
Roghaye Keshavarz Sadegh, Kiarash Saleki, Nima Rezaei. Immune checkpoint inhibitor (ICI) therapy in central nervous system cancers: State-of-the-art and future outlookInternational Immunopharmacology 2025; 159: 114837 doi: 10.1016/j.intimp.2025.114837